Product
pembrolizumab + carboplatin/paclitaxel followed by doxorubicin/cyclophosphamide
Name
pembrolizumab + carboplatin/paclitaxel followed by doxorubicin/cyclophosphamide
5 drugs
Drug
anti-PD-(L)1Drug
TQB2450Drug
TiragolumabDrug
R-CHOPDrug
cyclophosphamide